1. MTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28− Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection. Issue 5 (May 2020) Authors: Castro-Rojas, Cyd M.; Godarova, Alzbeta; Shi, Tiffany; Hummel, Sarah A.; Shields, Adele; Tremblay, Simon; Alloway, Rita R.; Jordan, Michael B.; Woodle, E. Steve; Hildeman, David A. Journal: Transplantation Issue: Volume 104:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗